Among other inflammatory mediators, there is a production of all families of chemokines in RA patients, including CXC, CC, CX3C, and C. Along with inflammation, the cellular antioxidant machinery reduces by reduced levels of nuclear factor-erythroid 2-related factor-2 (Nrf2). This evidence concerns the gene NFE2L2 and rheumatoid arthritis.